Press "Enter" to skip to content

New patent for Novartis Pharms drug ENTRESTO

0
Copyright © DrugPatentWatch. Originally published at New patent for Novartis Pharms drug ENTRESTO

Annual Drug Patent Expirations for ENTRESTO
Annual Drug Patent Expirations for ENTRESTO

Entresto is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

ENTRESTO drug price trends.

Drug patent litigation for ENTRESTO.

This drug has twenty-eight patent family members in twenty countries.

The generic ingredient in ENTRESTO is sacubitril; valsartan. One supplier is listed for this compound. Additional details are available on the sacubitril; valsartan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Novartis Pharms drug ENTRESTO
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions